BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 38491171)

  • 1. HDAC2 phosphorylation-dependent Klf5 deacetylation and RARα acetylation induced by RAR agonist switch the transcription regulatory programs of p21 in VSMCs.
    Zheng B; Han M; Shu YN; Li YJ; Miao SB; Zhang XH; Shi HJ; Zhang T; Wen JK
    Cell Res; 2011 Oct; 21(10):1487-508. PubMed ID: 21383775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II stimulates KLF5 phosphorylation and its interaction with c-Jun leading to suppression of p21 expression in vascular smooth muscle cells.
    He M; Han M; Zheng B; Shu YN; Wen JK
    J Biochem; 2009 Nov; 146(5):683-91. PubMed ID: 19628677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p21 and CK2 interaction-mediated HDAC2 phosphorylation modulates KLF4 acetylation to regulate bladder cancer cell proliferation.
    Jia ZM; Ai X; Teng JF; Wang YP; Wang BJ; Zhang X
    Tumour Biol; 2016 Jun; 37(6):8293-304. PubMed ID: 26729194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic retinoid Am80 inhibits interaction of KLF5 with RAR alpha through inducing KLF5 dephosphorylation mediated by the PI3K/Akt signaling in vascular smooth muscle cells.
    Zhang XH; Zheng B; Han M; Miao SB; Wen JK
    FEBS Lett; 2009 Apr; 583(8):1231-6. PubMed ID: 19292987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FoxF1 protects rats from paraquat-evoked lung injury following HDAC2 inhibition via the microRNA-342/KLF5/IκB/NF-κB p65 axis.
    Zheng F; Liu T; Zhu J; Xie Y; Wu L; Lin Z
    Exp Cell Res; 2020 Oct; 395(2):112208. PubMed ID: 32758486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of the transcription factor KLF5 in cardiovascular remodeling.
    Nagai R; Suzuki T; Aizawa K; Shindo T; Manabe I
    J Thromb Haemost; 2005 Aug; 3(8):1569-76. PubMed ID: 16102021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential role of KLF5 transcription factor in cell proliferation and differentiation and its implications for human diseases.
    Dong JT; Chen C
    Cell Mol Life Sci; 2009 Aug; 66(16):2691-706. PubMed ID: 19448973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase 2 controls p53 and is a critical factor in tumorigenesis.
    Wagner T; Brand P; Heinzel T; Krämer OH
    Biochim Biophys Acta; 2014 Dec; 1846(2):524-38. PubMed ID: 25072962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase‑2: A potential regulator and therapeutic target in liver disease (Review).
    Liu YR; Wang JQ; Huang ZG; Chen RN; Cao X; Zhu DC; Yu HX; Wang XR; Zhou HY; Xia Q; Li J
    Int J Mol Med; 2021 Jul; 48(1):. PubMed ID: 34013366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of histone acetylation and DNA methylation on p21( WAF1) regulation.
    Fang JY; Lu YY
    World J Gastroenterol; 2002 Jun; 8(3):400-5. PubMed ID: 12046058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial Expression of Concern: HDAC2 phosphorylation-dependent Klf5 deacetylation and RARα acetylation induced by RAR agonist switch the transcription regulatory programs of p21 in VSMCs.
    Zheng B; Han M; Shu YN; Li YJ; Miao SB; Zhang XH; Shi HJ; Zhang T; Wen JK
    Cell Res; 2024 Apr; 34(4):331. PubMed ID: 38491171
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.